脂肪性肝病的实用病理评估方法
本文针对肝活检中显著脂肪变性(累及≥5%肝实质)提出分步评估方法,强调区分单纯性脂肪变与脂肪性肝炎的重要性,后者因肝硬化及肝细胞癌等长期风险需随访。评估需结合用药、营养状况和酒精使用等临床病史,并给出统一报告示例及非酒精性脂肪性肝炎临床研究网络活动评分的使用建议。
要点
- 评估肝活检脂肪变性需按脂肪变程度、气球样变、小叶内炎症和纤维化四要素系统进行
- 区分单纯性脂肪变与脂肪性肝炎至关重要,后者需长期随访
- 诊断需结合用药、营养状态及酒精使用等临床病史
核心结论
- 有效评估脂肪变性肝活检需仔细组织学检查并结合临床病史,尤其关注用药、营养状况和酒精使用。
- 区分单纯性脂肪变与脂肪性肝炎至关重要,脂肪性肝炎因肝硬化及肝细胞癌等长期风险需要随访。
研究设计与样本
- 基于日常实践中遇到的脂肪肝病活检及近期文献,提出针对显著脂肪变性(累及≥5%肝实质)的分步评估方法。
主要发现
- 推荐按脂肪变程度、气球样变有无、小叶内炎症和纤维化四方面组织化评估脂肪变性肝活检。
- 文中提供分步评估示例、常见陷阱、鉴别诊断考虑及建议的诊断表述。
关键数值与推荐
- 显著脂肪变性定义为累及≥5%肝实质。
- 提供统一报告示例,包括非酒精性脂肪性肝炎临床研究网络活动评分的适当使用。
临床怎么用
- 病理科医生可按四步法系统评估脂肪变性肝活检并规范报告。
- 诊断时应结合用药、营养状况和酒精使用等临床信息进行综合判断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT.—: Fatty liver disease is now one of the most commonly encountered entities in the practice of liver pathology. Distinguishing simple steatosis from steatohepatitis is critical because the latter requires follow-up because of long-term risks that include cirrhosis and hepatocellular carcinoma. An organized approach for evaluating liver biopsies with steatosis is recommended to capture all of the relevant features: (1) degree of steatosis, (2) presence or absence of ballooning degeneration, (3) lobular inflammation, and (4) fibrosis. Herein, we provide a stepwise approach that readers can use to evaluate liver biopsies with steatosis, including examples, pitfalls, differential diagnostic considerations, and suggested diagnostic phrasing. OBJECTIVE.—: To provide a stepwise approach for the evaluation of liver biopsies showing significant steatosis (involving ≥5% of liver parenchyma). DATA SOURCES.—: Biopsies demonstrating fatty liver disease encountered in our daily practice were examined as well as recent literature. CONCLUSIONS.—: Effective evaluation of liver biopsies with steatosis requires careful histologic examination and correlation with clinical history, particularly regarding medications, nutrition status, and alcohol use. Examples of uniform reporting, including appropriate use of the nonalcoholic steatohepatitis Clinical Research Network Activity Score, are provided.
引用
- Mostafa M, Abdelkader A, Evans JJ, et al. Fatty Liver Disease: A Practical Approach. Arch Pathol Lab Med. 2019. PMID: 31603713. doi:10.5858/arpa.2019-0341-RA
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。